Trade Paratek Pharma - PRTK CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.05 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023429% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001207% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 2.17 |
| Open | 2.17 |
| 1-Year Change | -12.15% |
| Day's Range | 2.17 - 2.22 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Sep 20, 2023 | 2.22 | 0.05 | 2.30% | 2.17 | 2.22 | 2.17 |
| Sep 19, 2023 | 2.17 | 0.00 | 0.00% | 2.17 | 2.17 | 2.16 |
| Sep 18, 2023 | 2.16 | -0.01 | -0.46% | 2.17 | 2.18 | 2.16 |
| Sep 15, 2023 | 2.17 | -0.01 | -0.46% | 2.18 | 2.18 | 2.16 |
| Sep 14, 2023 | 2.17 | -0.01 | -0.46% | 2.18 | 2.18 | 2.17 |
| Sep 13, 2023 | 2.18 | -0.01 | -0.46% | 2.19 | 2.19 | 2.18 |
| Sep 12, 2023 | 2.19 | 0.00 | 0.00% | 2.19 | 2.19 | 2.19 |
| Sep 11, 2023 | 2.18 | -0.01 | -0.46% | 2.19 | 2.20 | 2.18 |
| Sep 8, 2023 | 2.19 | 0.01 | 0.46% | 2.18 | 2.19 | 2.18 |
| Sep 7, 2023 | 2.19 | 0.01 | 0.46% | 2.18 | 2.19 | 2.18 |
| Sep 6, 2023 | 2.18 | 0.01 | 0.46% | 2.17 | 2.19 | 2.17 |
| Sep 5, 2023 | 2.18 | 0.01 | 0.46% | 2.17 | 2.19 | 2.17 |
| Sep 1, 2023 | 2.17 | -0.02 | -0.91% | 2.19 | 2.20 | 2.17 |
| Aug 31, 2023 | 2.19 | 0.02 | 0.92% | 2.17 | 2.19 | 2.17 |
| Aug 30, 2023 | 2.18 | 0.01 | 0.46% | 2.17 | 2.20 | 2.17 |
| Aug 29, 2023 | 2.18 | 0.01 | 0.46% | 2.17 | 2.18 | 2.17 |
| Aug 28, 2023 | 2.17 | 0.01 | 0.46% | 2.16 | 2.18 | 2.16 |
| Aug 25, 2023 | 2.18 | 0.01 | 0.46% | 2.17 | 2.19 | 2.17 |
| Aug 24, 2023 | 2.18 | 0.02 | 0.93% | 2.16 | 2.18 | 2.16 |
| Aug 23, 2023 | 2.16 | 0.00 | 0.00% | 2.16 | 2.16 | 2.16 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Paratek Pharma Company profile
About Paratek Pharmaceuticals Inc
Paratek Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on the development and commercialization of novel life-saving therapies for life-threatening diseases. The Company's product include NUZYRA (omadacycline) is an oral and intravenous antibiotic for the treatment of community-acquired bacterial pneumonia and acute skin and skin structure infections caused by susceptible pathogens. Its other product includes SEYSARA, which is a oral therapy for the treatment of moderate to severe acne vulgaris.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Paratek Pharmaceuticals Inc revenues increased from $46.9M to $130.2M. Net loss decreased 39% to $59.1M. Revenues reflect Product revenue, net increase from $38.8M to $106.1M, Collaboration and royalty revenue increase from $1.5M to $8.2M, Government contract grant revenue increase from $3.4M to $9.2M. Lower net loss reflects Interest Expense decrease of 14% to $17.4M (expense).
Equity composition
Common Stock $.001 Par, 3/11, 100M auth., 13,467,933 issd. Insiders control 9.22%. IPO: 5/06 .3M shs. @ $6.50 per share by Bear, Stearns & Co. Inc. 02/09, Name changed from Novacea, Inc. 02/09, 5-for-1 reverse stock split. 10/14,1-for-12 reverse stock split.
| Industry: | Pharmaceuticals (NEC) |
75 Park Plaza
4th Floor
BOSTON
MASSACHUSETTS 02116
US
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com